These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 4355201)
21. Mode of action of N6-O2'-dibutyryl cyclic 3',5' AMP on fat cell metabolism. Jarett L; Smith RM Diabetes; 1974 Jan; 23(1):29-40. PubMed ID: 4358604 [No Abstract] [Full Text] [Related]
22. Effects of insulin on the lipolytic system of rat fat cells. Schönhöfer PS; Skidmore IF; Krishna G Horm Metab Res; 1972 Nov; 4(6):447-54. PubMed ID: 4347822 [No Abstract] [Full Text] [Related]
23. Controle of the metabolism and lipolytic effects of cyclic 3',5'-adenosine monophosphate in adipose tissue by insulin, methyl xanthines, and nicotinic acid. Blecher M; Merlino NS; Ro'Ane JT J Biol Chem; 1968 Jul; 243(14):3973-7. PubMed ID: 4298515 [No Abstract] [Full Text] [Related]
24. Solubilization and characterization of hormone- responsive phosphodiesterase activity of rat fat cells. Lovell-Smith CJ; Manganiello VC; Vaughan M Biochim Biophys Acta; 1977 Apr; 497(2):447-58. PubMed ID: 192314 [TBL] [Abstract][Full Text] [Related]
25. Effect of anti-insulin receptor antibodies on insulin-sensitive phosphodiesterase in rat fat cells. Suzuki T; Makino H; Kanatsuka A; Yoshida S Horm Metab Res; 1988 May; 20(5):257-60. PubMed ID: 2841215 [TBL] [Abstract][Full Text] [Related]
31. Selective inhibitors of specific phosphodiesterases in intact adipocytes. Manganiello V; Degerman E; Elks M Methods Enzymol; 1988; 159():504-20. PubMed ID: 2457789 [No Abstract] [Full Text] [Related]
32. An effect of insulin on the adenosine 3':5'-cyclic monophosphate phosphodiesterase and guanosine 3':5'-cyclic monophosphate phosphodiesterase activities in the perfused Langendorff and working hearts of normal and diabetic rats. Das I; Chain EB Biochem J; 1972 Jul; 128(3):95P-96P. PubMed ID: 4344014 [No Abstract] [Full Text] [Related]
33. Antilipolytic action of insulin on fat cells. Fain JN; Rosenberg L Diabetes; 1972; 21(2 Suppl):414-25. PubMed ID: 4340997 [No Abstract] [Full Text] [Related]
34. Study of phosphodiesterase inhibitors on lipolysis, phosphodiesterase activity and cyclic 3',5'-adenosine monophosphate levels in isolated fat cells. Allen DO; Clark JF; Ashmore J J Pharmacol Exp Ther; 1973 May; 185(2):379-85. PubMed ID: 4350040 [No Abstract] [Full Text] [Related]
35. Studies on pyrazinoylguanidine. 4. Upregulation of phosphodiesterase activity in rat adipose tissue and downregulation of gluconeogenesis and adenosine 3',5'-monophosphate concentrations in perfused rat liver. A-Rahim YI; Rannels SL; Kimball SR; Beyer KH; Vesell ES Pharmacology; 1996 Oct; 53(4):211-8. PubMed ID: 8958559 [TBL] [Abstract][Full Text] [Related]
36. Characterization of insulin-sensitive phosphodiesterase in fat cells. I. Effects of salts and oxidation-reduction agents. Makino H; de Buschiazzo PM; Pointer RH; Jordan JE; Kono T J Biol Chem; 1980 Aug; 255(16):7845-9. PubMed ID: 6249817 [No Abstract] [Full Text] [Related]
37. Cyclic 3',5'-AMP phosphodiesterase in isolated fat cells. Simple and sensitive methods for the assay of phosphodiesterase activity in fat cells and studies of the enzyme inhibition by theophylline. Schönhöfer PS; Skidmore IF; Bourne HR; Krishna G Pharmacology; 1972; 7(2):65-77. PubMed ID: 4340944 [No Abstract] [Full Text] [Related]
38. Studies of the effect of nicotinic acid on cyclic nucleotide phosphodiesterase activity in rat heart and adipose tissue. Therriault DG; Winters VG Life Sci I; 1970 Apr; 9(8):421-8. PubMed ID: 4323330 [No Abstract] [Full Text] [Related]